Public-Health Impact of Delayed Access to Neoadjuvant-Adjuvant Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in Brazil

Clinical Breast Cancer · Elsevier

Аннотация

Publication date: Available online 16 November 2026 Source: Clinical Breast Cancer Author(s): Angela Theresa Zuffo Yabrude, Leila Caroline Souza Reis, Ana Elisa Saragossa Zafalon, Lorrany Larisse Costa Rodrigues, Clara Fish Araujo de Albuquerque, Eliza Del Fiol Manna

Читать у издателя →

Похожие статьи